U.S. Food, 2026-11-20: The federal application list for mebendazole shows three approved applications: Janssen's NDA 017481 (100 mg), Janssen's NDA 208398 (500 mg), both discontinued, and ANDA 073580 approved 4 January 1995 to Impax for Emverm, still listed as prescription.
Discontinued
U.S. Food, 2026-11-20: The federal application list for mebendazole shows three approved applications: Janssen's NDA 017481 (100 mg), Janssen's NDA 208398 (500 mg), both discontinued, and ANDA 073580 approved 4 January 1995 to Impax for Emverm, still listed as prescription. Record field transcription of an FDA JSON API response (not prose), hence MEDIUM. Access date 2026-11-19. The human-facing Drugs@FDA HTML pages (scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017481) returned an FDA error page to this network on the access date, so the API endpoint is cited; the same records drive Drugs@FDA. Original approval dates: NDA017481 1974-06-28; ANDA073580 1995-01-04; NDA208398 2016-10-19. No other ANDA for mebendazole exists in the file.
